Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06273891 · ClinicalTrials.gov registry record · Phase 3
Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes
A Phase 3 study of Premature Rupture of Membrane, sponsored by Inova Health Care Services.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 140
- Enrollment target
- 2
- Study locations
NCT06273891 is a Phase 3 study of Premature Rupture of Membrane that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 140 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT06273891, a Phase 3 study of Premature Rupture of Membrane, is actively recruiting participants, sponsored by Inova Health Care Services.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this study is to help identify the best antibiotic treatment for pregnant people when their water breaks prematurely (a condition abbreviated as PPROM). Current practice is to attempt to maintain the pregnancy until at least 34 weeks gestational age, when the risks of prematurity to the baby are lessened. Research shows that antibiotics help the pregnancy last longer, but there have been limited studies about which combination works best. Currently, both azithromycin and erythromycin are accepted antibiotic treatments, in addition to ampicillin and amoxicillin. Participants diagnosed with PPROM will be randomized to receive ampicillin and amoxicillin plus either azithromycin or erythromycin, in addition to the care they would normally receive. Studying these two drugs will help decide the best care for future patients with PPROM.
Conditions Studied
Interventions
- DRUG Azithromycin
- DRUG Erythromycin
Study Locations (2)
Virginia
- Inova Fairfax Medical Campus - Falls Church
- Eastern Viriginia Medical School - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2024-03-08 |
| Est. Completion | 2026-10-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06273891
The ClinicalTrials.gov registry entry for NCT06273891 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Premature Rupture of Membrane appearing as the primary indexed condition, and to 2 interventions - of which Azithromycin is the first listed.
NCT06273891 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06273891 about?
NCT06273891 is a clinical study titled "Erythromycin Versus Azithromycin for Preterm Prelabor Rupture of Membranes". The goal of this study is to help identify the best antibiotic treatment for pregnant people when their water breaks prematurely (a condition abbreviated as PPROM). Current practice is to attempt to maintain the pregnancy until at least 34 weeks gestational age, when the risks of prematurity to the ...
What is the current status of trial NCT06273891?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 140 participants. The study started on 2024-03-08. Estimated completion is 2026-10-01.
What conditions does trial NCT06273891 study?
This clinical trial studies the following conditions: Premature Rupture of Membrane.
What interventions are being tested in trial NCT06273891?
The interventions under investigation include: Azithromycin (DRUG), Erythromycin (DRUG).
Who is sponsoring clinical trial NCT06273891?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06273891 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Rupture of Membrane
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.